Ebitda تغيير تاريخ
Abbott USD 2.41B 132M 2023-12
Acadia Pharmaceuticals USD 36.58M 92.63M 2023-12
Agios Pharmaceuticals USD -104874000 5.6M 2023-12
Alnylam Pharmaceuticals USD -102922000 330.12M 2023-12
AstraZeneca USD 3.43B 412M 2023-09
BioMarin Pharmaceutical USD 55.08M 3.73M 2023-12
Bluebird Bio USD -83657000 670K 2023-09
Eli Lilly USD 3.84B 1.88B 2023-09
Esperion Therapeutics USD -27507000 9.5M 2023-09
Halozyme Therapeutics USD 121.73M 10.37M 2023-12
Illumina USD -10000000 242M 2023-12
Insmed USD -159156000 23.92M 2023-12
Ironwood Pharmaceuticals USD 43.72M 1.49M 2023-12
J&J USD 6.46B 1.51B 2023-12
MannKind USD 11.98M 7.82M 2023-12
Merck USD 7.51B 11.02B 2023-09
Moderna USD 209M 1.97B 2023-12
PTC Therapeutics USD 88.72M 144.83M 2023-12
Sarepta Therapeutics USD -9914000 112.81M 2023-09
Thermo Fisher Scientific USD 2.79B 12M 2023-12
Ultragenyx Pharmaceutical USD -137906000 4.69M 2023-09
United Therapeutics USD 277.4M 62.9M 2023-12
Vanda Pharmaceuticals USD -2489000 5.16M 2023-06



Lexicon Pharmaceuticals - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2024.